AIM ImmunoTech Inc (AIM)
0.459
+0.04
(+9.29%)
USD |
NYAM |
Apr 23, 10:15
AIM ImmunoTech Total Assets (Quarterly): 19.38M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.38M |
| September 30, 2023 | 27.86M |
| June 30, 2023 | 33.62M |
| March 31, 2023 | 37.46M |
| December 31, 2022 | 40.49M |
| September 30, 2022 | 46.28M |
| June 30, 2022 | 50.88M |
| March 31, 2022 | 54.16M |
| December 31, 2021 | 57.70M |
| September 30, 2021 | 63.08M |
| June 30, 2021 | 66.72M |
| March 31, 2021 | 74.09M |
| December 31, 2020 | 64.58M |
| September 30, 2020 | 64.16M |
| June 30, 2020 | 50.12M |
| March 31, 2020 | 42.41M |
| December 31, 2019 | 20.75M |
| September 30, 2019 | 22.49M |
| June 30, 2019 | 13.81M |
| March 31, 2019 | 15.96M |
| December 31, 2018 | 13.84M |
| September 30, 2018 | 15.17M |
| June 30, 2018 | 15.68M |
| March 31, 2018 | 16.26M |
| December 31, 2017 | 14.21M |
| Date | Value |
|---|---|
| September 30, 2017 | 14.72M |
| June 30, 2017 | 16.11M |
| March 31, 2017 | 16.86M |
| December 31, 2016 | 18.87M |
| September 30, 2016 | 21.58M |
| June 30, 2016 | 21.92M |
| March 31, 2016 | 21.50M |
| December 31, 2015 | 22.80M |
| September 30, 2015 | 26.50M |
| June 30, 2015 | 29.87M |
| March 31, 2015 | 30.79M |
| December 31, 2014 | 29.44M |
| September 30, 2014 | 30.64M |
| June 30, 2014 | 33.55M |
| March 31, 2014 | 35.01M |
| December 31, 2013 | 31.87M |
| September 30, 2013 | 42.88M |
| June 30, 2013 | 46.14M |
| March 31, 2013 | 51.66M |
| December 31, 2012 | 57.70M |
| September 30, 2012 | 48.58M |
| June 30, 2012 | 41.11M |
| March 31, 2012 | 42.73M |
| December 31, 2011 | 43.51M |
| September 30, 2011 | 45.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.81M
Minimum
Jun 2019
74.09M
Maximum
Mar 2021
44.74M
Average
46.28M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Electromed Inc | 46.96M |
| Xtant Medical Holdings Inc | 92.61M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.147M |
| Shareholders Equity (Quarterly) | 10.23M |
| Current Ratio | 1.682 |